In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes
Abstract After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugsĀ have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in theĀ replication cycle of the novel coronavirus. Honeybee products are well known of their nutritional values and medicinal effects. Bee products…